Importantly, atypical trafficking of TRPC3 channels can lead to diseases, including cardiac hypertrophy, hypertension, and Alzheimer’s disease (Tano et al., 2010; Smedlund et al., 2012; Tiapko and Groschner, 2018). Here, TRPC3 is linked to cardiac hypertrophy.